ANSI 165. B API600 Cast Steel Flanged Gate Valve (Z40H)

YI CHEN ANSI 165.B API600 Cast Steel Gate Valve (Z40H)

Product Description

ANSI Gate Valve (cast steel)

Brief introduction:
The series of gate valves include cast steel gate valve and forged steel gate valve.They are designed and manufactured according to ANSI B16.34.With solid wedge and flexible wedge, so it can be used for different pressures.Gate valves have back seal.Back seal of forged-steel gate valve is weld with stainless steel.So it has perfect sealing.Its maintenance is convenient.Widely used in petroleum,chemistry,water treatment industries.

Features:

- "H" type wedge:
Gate valve has "H" type , flexible single wedge.It can compensate the distortion of body.So it has reliable sealing and prevent wedge against difficult operation because of overload.It is suitable to steam and other high temperature medium.

- Full port design:
Gate valve has full port.So it is convenient to clear pipeline.- Changeable seat:
Seat and body is connected with thread.So seat can be dismantled and changed, It is convenient to maintenance.

- Precise design:
Design the body and bonnet according to precise calculation.Body and bonnet have high strength , rigid and flow ability

Technical Specification
-Nominal diameter:2"-24"
-Nominal pressure:150Lb 300Lb 600Lb 900Lb 1500Lb
-Applicable Medium:Water ,gas,oil,and other causticity medium.

Applications Standard
-Manufacture standard :ANSI B16.34
-Face to face dimension:ANSI B 16.10
-Flange dimension:ANSI B 16.5.MSS-SP-44
-Test:API 598.API 6D
     
FAQ
1.Q:What is your main market?
A:Our main market is North America, South America, Eastern Europe, Southeast Asia, Africa, Mid East, Eastern Asia, Western Europe.
2.Q:Are there products standard?
A:Our model is standard, if you have specific demand, pls tell us.
3.Q:Do you have interest to do our own design items?
A:Absolutely!It's our pleasure.
Our Services
1)Our advantage:
We are the manufacturer with almost 20 years experience on valves.Best price,quality and service, Also we can control the production status.Shanghai YI CHEN team with strong ability in designing and after sell service.Cooperation with Carrier has improved our quality to a new level.
2)Terms of payment:T/T, L/C, Western union.
3)Shipment:Average 20-25days after receiving deposit.
4)Delivery:Shanghai/Ningbo ,by sea or air.
5)Gurantee:One year since delivery.
6)Inspection:100% testing for all the valves.
7) All kinds of CERTIFICATE OF ORIGIN.
Welcome to choose SHANG HAI YI CHEN , we are always ready!
 

Apixaban API

Apixaban is a novel oral factor Xa inhibitor jointly developed by Bristol-Myers Squibb and Pfizer under the trade name Aldol, which is a novel oral anticoagulant. Apixaban prevents thrombin production and thrombosis by inhibiting an important clotting factor, Xa. On April 26, 2007, Bristol-Myers Squibb and Pfizer announced a collaboration to develop apaxaban, a new oral anticoagulant owned by BRIstol-Myers Squibb, as an upgraded alternative to warfarin. Under the agreement, Pfizer will make an upfront payment of $250 million to Bristol-Myers Squibb for 60 percent of the total development cost of apisaban, effective January 1, 2007, and Bristol-Myers Squibb will pay the remaining 40 percent, resulting in co-development and marketing rights for the drug. In May 2011, Apixaban was approved for the prevention of venous thrombosis in adults undergoing elective hip or knee replacement surgery in 27 European Union countries, Iceland and Norway. On 20 November 2012, the European Commission approved aldol (apisaban) for the prevention of stroke and systemic circulation embolism in adult patients with NVAF who have one or more risk factors for wind Chemicalbook. Subsequently, FDA of Canada, Japan and the United States approved Aldol? Apixaban is indicated for the prevention of stroke and systemic circulation embolism in adult patients with nonvalvular atrial fibrillation (NVAF) with one or more risk factors. On April 12, 2013, ELIQUIS (apisaban), a new Anticoagulant Drug jointly developed by Bristol-Myers Squibb and Pfizer, was officially launched in China. Aldol is a novel oral factor Xa inhibitor for the prevention of venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacement. Its marketing provides a safe and effective new alternative for clinical anticoagulation after orthopedic surgery, and brings good news to patients undergoing elective hip/knee replacement in China. Clinical studies have demonstrated that two oral doses of enoxaparin per day are better than one subcutaneous injection of enoxaparin 40mg per day. Apixaban 2.5mg is more effective in preventing venous thromboembolic events after hip or knee replacement surgery without increasing the risk of bleeding.

China Apixaban Cas 38560-30-4,Apixaban Cas 503615-03-0,Apixaban Cas 881386-01-2 ,Apixaban Cas 1267610-26-3,Apixaban Cas 536760-29-9,Apixaban Cas 545445-44-1,Good Stock Apixaban API Cas 503612-47-3,Commercial Apixaban BMS 562247-01,Best Quality Apixaban Eliquis etc.

China Apixaban Cas 503612-47-3 Supplier,Good Stock Apixaban API Cas 503612-47-3,Commercial Apixaban BMS 562247-01,Best Quality Apixaban Eliquis

 Shandong Haohong Biotechnology Co., Ltd. , https://www.haohongpharma.com